Mandate safe disposal of APIs and prevention of pharmaceutical residues in water

WHO EHS Guidelines: Include biosafety levels, cleanroom classification, and cross-contamination prevention

India Factories Act, 1948: Enforces worker health, safety, and welfare in manufacturing plants

CPCB & SPCBs: Monitor environmental clearances, emission norms, and ETP (Effluent Treatment Plant) functioning

Failure to comply with these can result in penalties, shutdowns, and license revocation. EHS compliance is also a critical part of pharma audit checklists.

3. Major EHS Risk Areas in Pharma Plants

Common EHS risks in pharmaceutical environments include:

3.1 Chemical Exposure

• APIs, solvents, acids, and reagents can cause respiratory and dermal hazards
• Inhalation of airborne particulates, especially in powder handling zones

3.2 Fire and Explosion

• Solvent storage and usage increase flammability risks
• Static discharge and improper earthing of equipment

3.3 Biological Hazards

• Biologics and vaccine manufacturing may involve live organisms or toxins

3.4 Equipment Hazards

• Mixers, centrifuges, autoclaves, and tablet presses pose pinch and crush risks

3.5 Ergonomic Issues

• Prolonged standing, manual material handling, and poor workstation design

3.6 Environmental Discharge

• ETP malfunction can release harmful effluents into water bodies
• API residues can harm aquatic ecosystems

Proper hazard identification and risk assessments must be conducted using tools like HIRA (Hazard Identification and Risk Assessment) and JSA (Job Safety Analysis).

4. Best Practices for EHS Compliance

Building a culture of safety requires continuous implementation of the following:

4.1 EHS Policy and SOPs

• Define a company-wide EHS policy signed by top management
• Develop SOPs for hazardous waste, PPE usage, chemical spill response, and fire drills

4.2 Training and Competency

• Conduct induction and refresher training programs
• Use mock drills, toolbox talks, and visual safety instructions

4.3 Incident Reporting and Root Cause Analysis

• Near misses and injuries must be reported promptly
• Perform RCA and implement corrective actions

4.4 ETP and Air Emission Monitoring

• Maintain online data loggers for pH, BOD, COD, TDS, and flow rates
• Ensure STP/ETP is properly maintained and validated

4.5 GHS Labeling and MSDS Availability

• Follow Globally Harmonized System (GHS) for hazard communication
• Keep MSDS accessible at every location where chemicals are handled

4.6 Engineering Controls

• Install LEV (local exhaust ventilation), fire alarms, eye wash stations, and isolation valves
• Follow zoning and color-coding of risk areas

Refer to Pharma Validation for checklists to validate ETPs and HVAC systems for compliance.

5. Documentation and Records for EHS Audits

Audit readiness depends on robust documentation. Maintain:

• EHS policy signed by site head
• SOPs and work instructions (WI) for safety-critical activities
• MSDS repository and chemical inventory log
• Training records and attendance logs
• Mock drill reports, evacuation records
• ETP operation logs and discharge analysis reports
• Incident investigation and CAPA records

Use software or logbooks for tracking safety KPIs like Lost Time Injury Frequency Rate (LTIFR) and Near Miss Frequency Rate (NMFR).

6. Cross-Linking EHS with Other Compliance Systems

EHS cannot operate in isolation. It must be integrated with:

• GMP compliance: Personal hygiene, pest control, waste handling
• Quality Risk Management: Assess safety risks as part of QRM
• CSV & ERES: Monitor safety-critical systems like alarms and access control
• Packaging: Fire-retardant secondary packaging, label warnings

Integration also ensures EHS gets reflected in regulatory submissions for new plant approvals and environmental clearances.

7. EHS Metrics and Continual Improvement

Implement periodic review using KPIs like:

• Number of incidents per 100 employees
• Compliance with training schedule (%)
• Closure rate of safety CAPAs
• Number of unsafe conditions reported
• External non-compliance observations from CPCB/SPCB

Management review meetings should include EHS status, audit findings, legal updates, and improvement goals.

8. Sustainability and Green Chemistry Initiatives

Pharmaceutical companies are adopting EHS-driven sustainability practices such as:

• Use of low VOC solvents and green reagents
• Solvent recovery and reuse
• Rainwater harvesting and energy-efficient HVAC
• Reducing carbon footprint through solar panels and LED lighting

These not only improve compliance but also align with ESG (Environmental, Social, Governance) objectives.

9. Role of EHS Teams and Committees

Effective EHS implementation requires:

• Site-level EHS Manager and dedicated team
• Monthly Safety Committee meetings with cross-functional representation
• Regular inspections and audits
• Collaboration with HR for EHS training matrix

Employees must be empowered to stop unsafe work, raise concerns, and suggest improvements.

10. Conclusion

Environmental, Health & Safety regulations are central to responsible pharmaceutical manufacturing. Compliance not only protects life and the environment but also secures business continuity and global market access.

Companies must proactively invest in training, technology, SOPs, audit readiness, and continuous monitoring to maintain a safe and compliant workplace. When integrated with quality and regulatory systems, EHS creates a culture of care, accountability, and excellence.

For downloadable EHS SOPs, audit templates, compliance checklists, and ETP validation guidance, visit Pharma SOP and Stability Studies.